Avicanna Inc. has recently introduced a significant real-world evidence study on medical cannabis through the MyMedi.ca medical cannabis care platform. This study will be overseen by Hance Clarke, MD, FRCPC, Ph.D., who currently serves as the president of The Canadian Pain Society and the Canadian Consortium for the Investigation of Cannabinoids.
For more detailed information on this announcement, please refer to the full article provided in this link.
In addition to this, here are some top cannabis news stories from the past week:
1. Tilray has revealed a new lineup of hemp-derived delta-9 THC drinks.
2. GCAC and Grunt Style Foundation are set to launch a partnership at MCON 2024.
3. Cannabix Technologies and Omega Laboratories Inc. have made advancements in marijuana breathalyzer technology.
Furthermore, the article presents a list of the top cannabis stocks from September 20 to September 26, 2024. Please note that the information shared in this article is for informational purposes only and should not be considered as investment advice. Click here for the full disclaimer information.
